This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Select Medical (SEM) Rides on a Diversified Business Profile
by Zacks Equity Research
Select Medical's (SEM) supremacy in a fragmented market and its affordable healthcare services in each of its business segments bode well for the long haul.
Tenet Healthcare (THC) to Rejig Business by Selling Urgent Care
by Zacks Equity Research
Tenet Healthcare (THC) to restructure its ambulatory care business by axing the urgent care business and focusing on growing the ambulatory surgery business.
Community Health (CYH) Unit Offers Notes $2.8B in Two Tranches
by Zacks Equity Research
Community Health's (CYH) wholly-owned arm exhibits monetary discretion by issuing notes to procure funds.
Tenet Healthcare (THC) to Buy 45 Ambulatory Surgery Centers
by Zacks Equity Research
Tenet Healthcare (THC) to purchase 45 ambulatory surgery centers to aid its USPI ambulatory business, thus bolstering its position as a national musculoskeletal services leader in healthcare.
Implied Volatility Surging for Community Health (CYH) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Community Health (CYH) stock based on the movements in the options market lately.
Acadia Healthcare (ACHC) Up 54% in 6 Months: More Room to Run?
by Zacks Equity Research
Acadia Healthcare (ACHC) gains on the back of rising demand for its behavioral healthcare services, business rejig, cost-controlling efforts and strong cash flows.
Ensign Group (ENSG) Hits 52 Week High: Will the Rally Continue?
by Zacks Equity Research
Ensign Group (ENSG) evolves as an investor favorite stock, aided by its strategic initiatives, leading to improved revenues.
Community Health (CYH) Soars 168.6% YTD: More Room to Run?
by Zacks Equity Research
Community Health's (CYH) strategic measures along with the surge in telehealth visits are likely to fetch revenues, which in turn, may bump up its share price.
Reasons to Add Acadia Healthcare (ACHC) to Your Portfolio
by Zacks Equity Research
Better-than-expected Q3 results, positive estimate revisions, high demand for services, bed expansion, business streamlining make Acadia Healthcare (ACHC) an attractive investment bet.
Community Health's (CYH) Earnings Beat in Q3, Improve Y/Y
by Zacks Equity Research
Community Health's (CYH) third-quarter earnings gain from lower costs. However, the same is offset to some extent due to soft admissions.
Community Health Systems (CYH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Community Health Systems (CYH) delivered earnings and revenue surprises of 80.00% and 5.92%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Community Health Systems (CYH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Community Health Systems (CYH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Universal Health (UHS) for Now
by Zacks Equity Research
Riding high on its solvency position, strong segments and strategic initiatives, Universal Health (UHS) holds potential to reap benefits.
Here's Why You Should Retain Tenet Healthcare (THC) Stock
by Zacks Equity Research
Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.
HCA Healthcare (HCA) Announces Preliminary Results for Q3
by Zacks Equity Research
HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks Equity Research
HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.
Acadia Healthcare Offers Senior Unsecured Notes for $475M
by Zacks Equity Research
Acadia Healthcare (ACHC) exhibits sharp business acumen by issuing senior notes to procure funds.
Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC
by Zacks Equity Research
Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC
UHS or THC: Which is a Better-Positioned Stock Right Now?
by Zacks Equity Research
Universal Health (UHS) and Tenet Healthcare (THC) are poised to grow. On comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Riding high on segmental contributions and a solid balance sheet, Universal Health (UHS) has potential to reap benefits for investors.
What Makes Select Medical (SEM) an Attractive Investment Pick
by Zacks Equity Research
Solid operating fundamentals and rising earnings estimate make Select Medical (SEM) a lucrative stock.
Acadia Healthcare, Covenant Health to Offer Mental Healthcare
by Zacks Equity Research
Acadia Healthcare (ACHC) and Covenant Health to unveil East Tennessee Behavioral Health to cater to the mental care services of communities in and around Knoxville.
Zacks.com featured highlights include: BXC, DBD, ARCB, CYH and CLW
by Zacks Equity Research
Zacks.com featured highlights include: BXC, DBD, ARCB, CYH and CLW
Why Should You Retain HCA Healthcare in Your Portfolio?
by Zacks Equity Research
Gaining traction from strategic moves and a solid uptake of telehealth medicines, HCA Healthcare (HCA) holds prospects of reaping benefits for investors.
5 Stocks That Brokers Favor Amid Coronavirus Crisis
by Maharathi Basu
In view of their thorough knowledge of the investing world, advice from brokers is necessary to design a winning portfolio of stocks in these coronavirus-ravaged times.